177 related articles for article (PubMed ID: 18639454)
1. Exploration of a fundamental substituent effect of alpha-ketoheterocycle enzyme inhibitors: Potent and selective inhibitors of fatty acid amide hydrolase.
DeMartino JK; Garfunkle J; Hochstatter DG; Cravatt BF; Boger DL
Bioorg Med Chem Lett; 2008 Nov; 18(22):5842-6. PubMed ID: 18639454
[TBL] [Abstract][Full Text] [Related]
2. Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase.
Romero FA; Du W; Hwang I; Rayl TJ; Kimball FS; Leung D; Hoover HS; Apodaca RL; Breitenbucher JG; Cravatt BF; Boger DL
J Med Chem; 2007 Mar; 50(5):1058-68. PubMed ID: 17279740
[TBL] [Abstract][Full Text] [Related]
3. Optimization of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.
Kimball FS; Romero FA; Ezzili C; Garfunkle J; Rayl TJ; Hochstatter DG; Hwang I; Boger DL
J Med Chem; 2008 Feb; 51(4):937-47. PubMed ID: 18247553
[TBL] [Abstract][Full Text] [Related]
4. α-Ketoheterocycle inhibitors of fatty acid amide hydrolase: exploration of conformational constraints in the acyl side chain.
Duncan KK; Otrubova K; Boger DL
Bioorg Med Chem; 2014 May; 22(9):2763-70. PubMed ID: 24690529
[TBL] [Abstract][Full Text] [Related]
5. Correlation of inhibitor effects on enzyme activity and thermal stability for the integral membrane protein fatty acid amide hydrolase.
Slaymaker IM; Bracey M; Mileni M; Garfunkle J; Cravatt BF; Boger DL; Stevens RC
Bioorg Med Chem Lett; 2008 Nov; 18(22):5847-50. PubMed ID: 18644727
[TBL] [Abstract][Full Text] [Related]
6. X-ray crystallographic analysis of alpha-ketoheterocycle inhibitors bound to a humanized variant of fatty acid amide hydrolase.
Mileni M; Garfunkle J; Ezzili C; Kimball FS; Cravatt BF; Stevens RC; Boger DL
J Med Chem; 2010 Jan; 53(1):230-40. PubMed ID: 19924997
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics.
Boger DL; Miyauchi H; Du W; Hardouin C; Fecik RA; Cheng H; Hwang I; Hedrick MP; Leung D; Acevedo O; Guimarães CR; Jorgensen WL; Cravatt BF
J Med Chem; 2005 Mar; 48(6):1849-56. PubMed ID: 15771430
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and characterization of α-ketoheterocycles that additionally target the cytosolic port Cys269 of fatty acid amide hydrolase.
Otrubova K; Cravatt BF; Boger DL
J Med Chem; 2014 Feb; 57(3):1079-89. PubMed ID: 24456116
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.
Hardouin C; Kelso MJ; Romero FA; Rayl TJ; Leung D; Hwang I; Cravatt BF; Boger DL
J Med Chem; 2007 Jul; 50(14):3359-68. PubMed ID: 17559203
[TBL] [Abstract][Full Text] [Related]
10. Delineation of a fundamental alpha-ketoheterocycle substituent effect for use in the design of enzyme inhibitors.
Romero FA; Hwang I; Boger DL
J Am Chem Soc; 2006 Nov; 128(43):14004-5. PubMed ID: 17061864
[TBL] [Abstract][Full Text] [Related]
11. N-Acyl pyrazoles: Effective and tunable inhibitors of serine hydrolases.
Otrubova K; Chatterjee S; Ghimire S; Cravatt BF; Boger DL
Bioorg Med Chem; 2019 Apr; 27(8):1693-1703. PubMed ID: 30879861
[TBL] [Abstract][Full Text] [Related]
12. Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.
Garfunkle J; Ezzili C; Rayl TJ; Hochstatter DG; Hwang I; Boger DL
J Med Chem; 2008 Aug; 51(15):4392-403. PubMed ID: 18630870
[TBL] [Abstract][Full Text] [Related]
13. Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH).
Timmons A; Seierstad M; Apodaca R; Epperson M; Pippel D; Brown S; Chang L; Scott B; Webb M; Chaplan SR; Breitenbucher JG
Bioorg Med Chem Lett; 2008 Mar; 18(6):2109-13. PubMed ID: 18289847
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and evaluation of polar head group containing 2-keto-oxazole inhibitors of FAAH.
Rusch M; Zahov S; Vetter IR; Lehr M; Hedberg C
Bioorg Med Chem; 2012 Jan; 20(2):1100-12. PubMed ID: 22196515
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors.
Tarzia G; Duranti A; Tontini A; Piersanti G; Mor M; Rivara S; Plazzi PV; Park C; Kathuria S; Piomelli D
J Med Chem; 2003 Jun; 46(12):2352-60. PubMed ID: 12773040
[TBL] [Abstract][Full Text] [Related]
16. Discovery of an exceptionally potent and selective class of fatty acid amide hydrolase inhibitors enlisting proteome-wide selectivity screening: concurrent optimization of enzyme inhibitor potency and selectivity.
Leung D; Du W; Hardouin C; Cheng H; Hwang I; Cravatt BF; Boger DL
Bioorg Med Chem Lett; 2005 Mar; 15(5):1423-8. PubMed ID: 15713400
[TBL] [Abstract][Full Text] [Related]
17. Identification of highly potent N-acylethanolamine acid amidase (NAAA) inhibitors: Optimization of the terminal phenyl moiety of oxazolidone derivatives.
Li Y; Chen Q; Yang L; Li Y; Zhang Y; Qiu Y; Ren J; Lu C
Eur J Med Chem; 2017 Oct; 139():214-221. PubMed ID: 28802121
[TBL] [Abstract][Full Text] [Related]
18. Chiral 3-(4,5-dihydrooxazol-2-yl)phenyl alkylcarbamates as novel FAAH inhibitors: Insight into FAAH enantioselectivity by molecular docking and interaction fields.
Myllymäki MJ; Käsnänen H; Kataja AO; Lahtela-Kakkonen M; Saario SM; Poso A; Koskinen AM
Eur J Med Chem; 2009 Oct; 44(10):4179-91. PubMed ID: 19539407
[TBL] [Abstract][Full Text] [Related]
19. Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase.
Minkkilä A; Saario SM; Käsnänen H; Leppänen J; Poso A; Nevalainen T
J Med Chem; 2008 Nov; 51(22):7057-60. PubMed ID: 18983140
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Uracil Derivatives as Potent Inhibitors of Fatty Acid Amide Hydrolase.
Qiu Y; Zhang Y; Li Y; Ren J
Molecules; 2016 Feb; 21(2):. PubMed ID: 26901181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
